In a breakthrough that could reshape the future of cancer care, Nanocrine--a Maryland-based biotech startup--has unveiled its RT-Chip(TM) technology, a next-generation biosensor platform that enables ...

Cancer is often most dangerous when it hides in the early stages. Detecting it before symptoms appear is one of the biggest challenges in modern medicine. Now, researchers from the Korea Institute of ...

Sarcosine, a metabolite that has emerged as a promising biomarker for prostate cancer, has spurred the development of innovative biosensing technologies aimed at non-invasive, rapid, and highly ...

A quantitative and systematic review showed that ultrasonography with color Doppler is a useful preoperative test for predicting the diagnosis of pelvic masses, with a pooled sensitivity of 0.87 and a ...

Saliva and plasma could be crucial in detecting recurrences or relapses of head and neck cancers, negating the need for a ...

Genetic material shed by tumors can be detected in the bloodstream three years prior to cancer diagnosis, according to a study led by investigators at Johns Hopkins University. The study, partly ...

Before a malignant tumor is developed, the immune system tries to fight against proteins that are altered during their formation, producing certain cancer antibodies. A biosensor developed by ...

For many people living with cancer, symptoms such as pain, anxiety or insomnia can quickly spiral into an emergency room ...

The increase in early-onset cancers is not necessarily due to a rise in clinically meaningful cancers, researchers argued, but may be due to increased diagnostic scrutiny and overdiagnosis. Of the ...

As an oncologist, I see patients who report both common and uncommon symptoms. The symptoms most commonly linked to a cancer diagnosis, not surprisingly, reflect the incidence rates of the world’s ...